Chicago Trust’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
11,197
+37
+0.3% +$3.1K 0.15% 143
2026
Q1
$894K Sell
11,160
-907
-8% -$74.8K 0.14% 145
2025
Q4
$1.03M Buy
12,067
+63
+0.5% +$5.17K 0.16% 115
2025
Q3
$934K Buy
12,004
+341
+3% +$26.6K 0.13% 143
2025
Q2
$912K Buy
11,663
+6,158
+112% +$459K 0.13% 148
2025
Q1
$399K Sell
5,505
-157
-3% -$11.2K 0.07% 238
2024
Q4
$419K Sell
5,662
-570
-9% -$39.9K 0.07% 223
2024
Q3
$411K Buy
6,232
+1,383
+29% +$100K 0.07% 239
2024
Q2
$448K Sell
4,849
-457
-9% -$40.5K 0.09% 189
2024
Q1
$507K Buy
5,306
+381
+8% +$32K 0.1% 179
2023
Q4
$376K Sell
4,925
-19
-0.4% -$1.32K 0.08% 200
2023
Q3
$343K Sell
4,944
-464
-9% -$37.3K 0.09% 207
2023
Q2
$510K Buy
5,408
+105
+2% +$9.13K 0.12% 166
2023
Q1
$439K Buy
5,303
+117
+2% +$9.2K 0.11% 179
2022
Q4
$387K Buy
5,186
+173
+3% +$13.3K 0.1% 197
2022
Q3
$414K Buy
5,013
+8
+0.2% +$770 0.11% 185
2022
Q2
$476K Sell
5,005
-363
-7% -$37.6K 0.12% 171
2022
Q1
$632K Sell
5,368
-245
-4% -$27.5K 0.14% 158
2021
Q4
$727K Sell
5,613
-96
-2% -$11.2K 0.14% 160
2021
Q3
$646K Buy
5,709
+1,846
+48% +$211K 0.14% 168
2021
Q2
$400K Buy
+3,863
New +$364K 0.09% 207

Other funds holding EW

Chicago Trust's EW Position: Q2 2026 in Review

Chicago Trust increased its Edwards Lifesciences (EW) stake by 0.33% in Q2 2026, buying an estimated $3.1K and bringing the position to 11,197 shares worth $1.01M. The position accounts for 0.15% of the portfolio, ranked #143.

Chicago Trust first reported a position in EW in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.03M in Q4 2025. 287 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Chicago Trust held 11,197 shares of Edwards Lifesciences worth $1.01M as of Q2 2026.
  • Chicago Trust bought 37 Edwards Lifesciences shares in Q2 2026, an estimated $3.1K.
  • Edwards Lifesciences made up 0.15% of Chicago Trust's portfolio in Q2 2026, its #143 holding.
  • Chicago Trust first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 21 quarters since.
  • Chicago Trust's Edwards Lifesciences position peaked at $1.03M in Q4 2025.
  • 287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Chicago Trust's 13F filing for Q2 2026, filed 16 Jul 2026.